Comparison of two different generations of ‘‘NIRS’’ devices and transducers in healthy volunteers and ICU patients
Author
dc.contributor.author
Luengo Messen, Cecilia
es_CL
Author
dc.contributor.author
Resche Rigon, Matthieu
es_CL
Author
dc.contributor.author
Damoisel, Charles
es_CL
Author
dc.contributor.author
Kerever, Sébastien
es_CL
Author
dc.contributor.author
Creteur, Jacques
Author
dc.contributor.author
Payen, Didier
es_CL
Admission date
dc.date.accessioned
2014-01-24T18:23:25Z
Available date
dc.date.available
2014-01-24T18:23:25Z
Publication date
dc.date.issued
2013
Cita de ítem
dc.identifier.citation
J Clin Monit Comput (2013) 27:71–79
en_US
Identifier
dc.identifier.other
DOI 10.1007/s10877-012-9400-y
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129166
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
The purpose of this study is to compare Near
Infrared Spectroscopy (NIRS) thenar eminence parameters
obtained with 2 different devices from the same manufacturer
(InSpectra Models 325 and 650, Hutchinson Tech, Min
USA), and 2 different probes (15 vs. 25 mm spacing), in
healthy volunteers (HV) and ICU patients. Prospective,
observational study in ICU setting. Simultaneous, cross over
NIRS inter-device comparison and comparison between
different probes (25 vs. 15 mm spacing) were done at
baseline and during vascular occlusion tests (VOTs). Forty
patients (19 septic shock, 21 trauma), and 29 HV were
included. NIRS inter-device comparison showed similar
baseline StO2 values in HV and patients. The VOT result
were significantly different for minimal StO2 value reached
during VOT (StO2min) (intraclass concordance coefficient
(ICC) = 0.18), the occlusion slope (ICC = 0.16) and the
reperfusion slope (StO2reperf) (ICC = 0.26). The probe
comparison was also significantly different for VOT
parameters (StO2min (ICC = 0.43), occlusion (ICC = 0.50)
and StO2reperf (ICC = 0.48). The low concordance, poor
agreement and large bias (ICC and Bland & Altman)
observed, were related both to the device used and the probe
spacing. StO2 data obtained with NIRS model 650 and
15 mm probe differ from values obtained with the previous
device (325 and probe spacing 25 or 15 mm). This difference
is not related to the population tested, but to the device and
probe spacing. As a consequence, despite similar trends for
variations between HV and patients during VOT, threshold
and predictive values for outcome should be revisited with
the new device before the acceptance for routine clinical use.